• by bcarlson@marketresearch.com
  • April 28 2016


Abbott Adds Patient Monitoring Strength With St. Jude Buy

Abbott Adds Patient Monitoring Strength With St. Jude Buy

While Abbott’s purchase of St. Jude Medical will notably expand Abbott’s reach in heart devices, it also places Abbott into patient monitoring. Patient monitoring is one of the fastest growing device areas, with double-digit growth expected the next 5 years, according to Kalorama Information’s report, Advanced Remote Patient Monitoring

Abbott Laboratories agreed to acquire St. Jude Medical Inc. in a cash-and-stock deal valued at $25 billion that would create one of the leading makers of heart-...


Early Implications of the Zika Virus for the U.S. Diagnostics Market

Early Implications of the Zika Virus for the U.S. Diagnostics Market

In addition to its blog posts regarding infectious disease threats, Kalorama Information offers a comprehensive market research report for global infectious disease testing.

Since the last blog entry regarding Zika virus diagnostics, the U.S. Centers for Disease Control and Prevention (CDC) has issued emergency use authorizations (EUA) for a Zika IgM Antibody Capture ELISA (MAC-ELISA) kit and real-time reverse transcriptase PCR (RT-PCR) kit. Controls and kit reagents are available through the ...


World Vaccine Market Nears $28 Billion

World Vaccine Market Nears $28 Billion

Revenues earned by manufacturers of vaccines worldwide reached $27.6 billion in 2015, up from $24.7 billion in 2014 as sales in all segments expanded. This according to our most recent study Kalorama Information’s report: Vaccines 2016:World Market Analysis Kalorama finds that sales of pediatric vaccines constitute the larger market according to the report, accounting for 57.6% of the total vaccines market.. In 2015, global sales of pediatric vaccines exceeded $16.8 billion, increasing by 15.8% ...


After Allergan Merger Halt, Vaccines a Focus for Pfizer

New U.S. Treasury regulation has dissuaded Pfizer from its planned merger with Ireland-based Allergan. The two companies agreed on Tuesday to terminate the deal. The tax inversion move would have benefited Pfizer’s profitability and reintroduced the company to the dermatologics market. Pfizer will now consider business divestitures in order to boost its profits. Pfizer previously spun-off its animal health business in 2013, which now operates as the veterinary pharmaceuticals and diagnostics com...


Quest and DiaSorin to Focus on Key Markets Following Acquisition Deal

Quest and DiaSorin to Focus on Key Markets Following Acquisition Deal

This blog post reviews aspects of DiaSorin’s acquisition of Focus Diagnostics from Quest Diagnostics that are relevant to markets reviewed in Kalorama Information reports The World Market for Infectious Disease Diagnostic Tests , Clinical Laboratory Services Market , and Mergers and Acquisitions in the IVD Market.

At the end of March, Quest Diagnostics and DiaSorin S.p.A. announced the latter’s acquisition of Quest subsidiary Focus Diagnostics, Inc. for $300 million. The deal assists Quest Dia...